Murine Allogeneic in Vivo Stem Cell Homing(,)
Overview
Physiology
Affiliations
Stem cell homing has been studied in syngeneic models and appears to be rapid (<1 h) and dependent on cellular adhesion and migration factors. We utilized a full H2-mismatched transplantation model to determine the basics of allogeneic homing. C57BL/6J Lin-Sca-1+ cells were labeled with CFSE and injected in non-myeloablated BALB/c mice. Fluorescent cell detection was via high-speed FACS analysis. Alternatively, B6.SJL whole bone marrow cells were injected in lethally irradiated BALB/c mice (10 Gy). One, 3, 6, and 24 h after transplant, marrow was harvested and cells were either plated for high proliferative potential colony-forming cell (HPP-CFC) assay or secondarily injected into myeloablated (8 Gy) C57BL/6J mice using 10% competing C57BL/6J marrow. Chimerism was evaluated at 8 weeks. CFSE+ cells were detected in the bone marrow 1, 3, and 6 h after injection. The numbers were moderately lower when compared to syngeneic homing possibly due to strain effect. Conversely, utilizing a surrogate or secondary assay, we observed a decline of secondary engraftment of harvested cells over time, but not of HPP-CFC. Combining experiments and normalizing the 1-h time point to 100% (to allow comparison), we observed a mean relative engraftment of 87 +/- 29%, 72 +/- 21%, 84 +/- 35% of the 1 h level at 3, 6, and 24 h respectively. HPP-CFC assay showed no significant variation as a homing surrogate over 1-6 h. These data indicate a rapid homing into allogeneic recipients with a plateau at 1 h. The decline of secondary engraftability over time may indicate a phenotype alteration of homed cells.
Oliveira F, Nucci M, Mamani J, Alves A, Rego G, Kondo A Biomedicines. 2021; 9(7).
PMID: 34209598 PMC: 8301491. DOI: 10.3390/biomedicines9070752.
Ghosh S, Indracanti N, Joshi J, Indraganti P Front Immunol. 2017; 8:1180.
PMID: 28993772 PMC: 5622201. DOI: 10.3389/fimmu.2017.01180.
Cioffi M, Trabulo S, Vallespinos M, Raj D, Bou Kheir T, Lin M Oncotarget. 2017; 8(13):21609-21625.
PMID: 28423491 PMC: 5400610. DOI: 10.18632/oncotarget.15450.
Epigenetic reprogramming induces the expansion of cord blood stem cells.
Chaurasia P, Gajzer D, Schaniel C, DSouza S, Hoffman R J Clin Invest. 2014; 124(6):2378-95.
PMID: 24762436 PMC: 4038563. DOI: 10.1172/JCI70313.
FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis.
Coe L, Madathil S, Casu C, Lanske B, Rivella S, Sitara D J Biol Chem. 2014; 289(14):9795-810.
PMID: 24509850 PMC: 3975025. DOI: 10.1074/jbc.M113.527150.